Cervical cancer in developing countries: How canwe reduce the burden? Awareness raising, screening, treatment and palliation

Tropical Doctor

Volumn 37, Issue 2, 2007, Pages 67-70

  Ansink, Anca C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CISPLATIN; METRONIDAZOLE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; VIRUS DNA; WART VIRUS VACCINE; DIAGNOSTIC AGENT; PAPILLOMA VIRUS VACCINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVANCED CANCER; AWARENESS; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COMMUNITY CARE; CRYOCOAGULATION; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; EXTERNAL BEAM RADIOTHERAPY; GENITAL TRACT INFECTION; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; HYSTERECTOMY; IMMUNE DEFICIENCY; LEG PAIN; LOW BACK PAIN; LYMPH NODE METASTASIS; LYMPHEDEMA; MICTURITION; MULTIMODALITY CANCER THERAPY; PAPANICOLAOU TEST; PELVIS LYMPHADENECTOMY; PHYSICAL EXAMINATION; PUBLIC HEALTH PROBLEM; REPRODUCTIVE HEALTH; REVIEW; SEXUAL BEHAVIOR; SMOKING; URETER OBSTRUCTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VAGINA BLEEDING; VAGINA DISCHARGE; WART VIRUS; WOMEN'S HEALTH; ARTICLE; FEMALE; GENETICS; HEALTH PROMOTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MASS SCREENING; PALLIATIVE THERAPY; PAPILLOMA VIRUS; UTERINE CERVIX TUMOR; VACCINATION; VAGINA SMEAR;

HUMAN PAPILLOMAVIRUS;

ACETIC ACID; DEVELOPING COUNTRIES; DNA, VIRAL; FEMALE; HEALTH PROMOTION; HUMANS; MASS SCREENING; PALLIATIVE CARE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION; VAGINAL SMEARS;

EID: 34447334570     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/004947507780609284     Document Type: Review

References (28)

1. Parkin DM, Bray FI, Devassa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-66
2. Reproductive health outlook. Cervical cancer prevention http://www.rho.org/html/cxca.htm [accessed 11 January 2006]
3. Bekkers RL, Massuger LF, Bulten J, Melchers WJ. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol 2004;14:95-105 (Pubitemid 38316009)
4. Mandelblatt JS, Kanetsky P, Eggert L, Gold K. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epedemiol Biomarkers Prev 1999;8:97-106
5. Lowndes CM, Gill ON. Cervical cancer, human papillomavirus, and vaccination. BMJ 2005;331:915-916 (Pubitemid 41510841)
6. Koutsky LA, Ault KA, Wheeler CM et al. A controlled trial of human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645-1651 (Pubitemid 35340782)
7. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-278
8. Drain PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002;100:199-205 (Pubitemid 34666195)
9. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA 2001;285:3107-3115 (Pubitemid 32586089)
10. University of Zimbabwe/JHPIEGO cervical cancer project. Visual inspection with acetic acid for cervical cancer-cancer screening: test qualities in a primary-care setting. Lancet 1999;353:869-873
11. Denny L, Kuhn L, Pollack A, Wright TC. Direct visual inspection for cervical cancer screening. Cancer 2002;94:1699-1707
12. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings. Clinical benefits and cost-effectiveness. JAMA 2003;285:3107-3115
13. Sankaranaranayan R, Rajkumar R, Theresa R, et al. Initial results from a randomized trail of cervical visual screening in rural south India. Int J Cancer 2004;109:461-467 (Pubitemid 38252778)
14. Blumenthal PD, Gaffikin L, Chirenje ZM, McGrath J, Womack S, Shah K. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72:47-53 (Pubitemid 32007864)
15. Royal Thai college of Obstricians and Gynaecologists (RTCOG) and the JHPIEGO Corporation Cervical Cancer. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003;361:814-819
16. Soew A, Wong ML, Smith WC, Lee HP. Beliefs and attitudes as determinants of cervical screening: a community-based study in Singapore. Prev Med 1995;24:134-141
17. Gichangi P, Estambale B, Bwayo J, et al. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer 2003;13:827-833 (Pubitemid 38235228)
18. Gatune JW, Nyamongo IK. An ethnographic study of cervical cancer among women in rural Kenya: is there a folk causal model? Int J Gynceol Cancer 2005;15:1049-1059
19. Singh KK, Bloom SS, Tsui AO. Husbands' reproductive health knowledge, attitudes, and behaviour in Uttar Pradesh, India. Stud Fam Plann 1998;29:388-399 (Pubitemid 128617577)
20. Ritchie J, Lewis J, eds. Qualitative Research Practice. A Guide for Social Science Students and Researchers. London/Thousand Oaks/New Delhi: Sage, 2003
21. Symonds RP. Cancer of the cervix and vagina. In: Williams C, ed. Evidence-based Oncology. London: BMJ Books, 2003:402-410
22. Buckley SL, Tritz DM, Van Le L, et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol 1996;63:4-9 (Pubitemid 26337957)
23. Winter R. Conservative surgery for microinvasive carcinoma of the cervix. J Obstet Gynaecol 1998;24:433-436 (Pubitemid 29052048)
24. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 2001; CD002225
25. Dunst J, Kuhnt T, Strauss HG, et al. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 2003;56:778-787 (Pubitemid 36677372)
26. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-540 (Pubitemid 27348428)
27. WHO. Cancer Pain Relief. Geneva: World Health Organization, 1986
28. Biswal BM, Lal P, Rath GK, Mohanti BK. Hemostatic radiotherapy in carcinoma of the uterine cervix. Int J Gyn Obstet 1995;50:281-285